SANGAMO THERAPEUTICS, INC. (SGMOQ) Total liabilities 2016–2025
SANGAMO THERAPEUTICS, INC. (SGMOQ) total liabilities at each fiscal year-end, per SEC filings.
$74.0MFY2025 · since FY2016: $21.7M → $74.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $74.0M | -6.2% |
| FY2024 | $78.9M | -4.3% |
| FY2023 | $82.4M | -69.2% |
| FY2022 | $267.6M | -22.8% |
| FY2021 | $346.6M | -21.4% |
| FY2020 | $441.2M | +115.4% |
| FY2019 | $204.8M | -8.2% |
| FY2018 | $223.1M | +125.8% |
| FY2017 | $98.8M | +355.6% |
| FY2016 | $21.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice